Associated Papers
Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation.
Salfi G et al.
Frontiers in Oncology, 2025
Select a paper to view details